Moderna wins patent lawsuit against BioNTech/Pfizer
Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents
Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U.S. Patent Office tribunal that two patents Moderna accused them of infringing were invalid.
Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...
As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech ...
Discover the strengths & weaknesses of healthcare giants Johnson & Johnson and Pfizer. Find out which stock is more promising ...
"I was expecting him probably to win. It was very big win," Pfizer's CEO Albert Bourla said of President Donald Trump's ...
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...
The market sentiment in the next few months is likely to be quite positive for Pfizer. Read why I maintain my strong buy ...
U.S. President Donald Trump has issued a memorandum directing federal agencies to restrict inbound and outbound investments ...
Pfizer (PFE) announced that James List has joined the company as Chief Internal Medicine Officer. List will oversee Pfizer’s Internal Medicine ...
Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...
India Today on MSN11h
Pfizer Covid vaccine rushed to market, led to reproductive damages: Dr Naomi WolfWolf, who stated that she is not vaccinated against Covid-19, claimed that live birth rates have dropped by 13-20%, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback